Skylight Health Obtains Conditional Approval to List on NASDAQ Under the Symbol “SLHG”
May 13 2021 - 1:21PM
Skylight Health Group Inc. (TSXV:SHG; OTCQX: SHGFF) (“Skylight
Health” or the “Company”), a multi-state primary care management
group in the United States, today announced that the Company has
received conditional approval from The Nasdaq Stock Market LLC (
“Nasdaq”) to list its issued and outstanding common shares on
Nasdaq. Final approval of the listing is subject to the Company
fulfilling any remaining conditions as required by Nasdaq. The
Company expects to satisfy all of the requirements and will issue a
statement once a trading date has been confirmed by Nasdaq. The
Company’s common stock will continue to trade in Canada on the TSX
Venture Exchange under its current symbol SHG; and until the NASDAQ
listing, in the U.S. on the OTCQX under its current symbol, SHGFF.
“The anticipated listing of our stock on the Nasdaq represents a
significant milestone in our growth as a publicly-traded company,”
said Prad Sekar, CEO and Co-Founder of Skylight Health. “We believe
this anticipated listing will increase our visibility in the
marketplace, improve liquidity, broaden and diversify our
shareholder base, and ultimately enhance long-term shareholder
value. I would like to thank our employees, management, directors
and our many collaborators for their hard work in obtaining
conditional approval for Skylight Health to list on Nasdaq, an
important step that will help facilitate our mission to provide
primary services to Americans across the country.”
The Company also announces a change in auditor from Grant
Thornton LLP (“Former Auditor”) to PricewaterhouseCoopers LLP
(“Successor Auditor”) effective May 4, 2021. In accordance with NI
51-102, the notice of change of auditor, together with the required
letters from the Former Auditor and the Successor Auditor, have
been reviewed by the board of directors of the Company and filed on
SEDAR.
About Skylight Health Group
Skylight Health Group (TSXV:SHG; OTCQX:SHGFF) is
a healthcare services and technology company, working to positively
impact patient health outcomes. The Company operates a US
multi-state health network that comprises of physical
multi-disciplinary medical clinics providing a range of services
from primary care, sub-specialty, allied health and
laboratory/diagnostic testing. The Company owns and operates a
proprietary electronic health record system that supports the
delivery of care to patients via telemedicine and other remote
monitoring system integrations.
The Company primarily operates a traditional
insurable fee-for-service model contracting with Medicare, Medicaid
and other Commercial Payors. The Company also offers a disruptive
subscription-based telemedicine service for the un/under-insured
population who have limited access to urgent care due to cost.
For more information, please visit www.skylighthealthgroup.com
or contact:Investor Relations – USA:John
Evansjohn.evans@skylighthealthgroup.com
Investor Relations - Canada: Jackie
Kellyinvestors@skylighthealthgroup.com416-301-2949
Currency Usage, Cautionary and Forward-Looking
Statements
All currency contained in this Press Release represent Canadian
Dollars unless otherwise stated.
Statements in this news release that are forward-looking
statements are subject to various risks and uncertainties
concerning the specific factors disclosed here and elsewhere in
Skylight Health's filings with Canadian and United States
securities regulators. When used in this news release, words such
as "will, could, plan, estimate, expect, intend, may, potential,
believe, should," and similar expressions, are forward-looking
statements.
Forward-looking statements may include, without limitation,
statements regarding the Company’s anticipated uplist to
NASDAQ.
Although Skylight Health has attempted to identify important
factors that could cause actual results, performance or
achievements to differ materially from those contained in the
forward-looking statements, there can be other factors that cause
results, performance or achievements not to be as anticipated,
estimated or intended, including, but not limited to: the ability
of Skylight Health to execute on its business strategy, continued
revenue growth in accordance with management’s expectations,
operating expenses continuing in accordance with management
expectations, dependence on obtaining regulatory approvals;
Skylight Health being able to find, complete and effectively
integrate target acquisitions; change in laws relating to health
care regulation; reliance on management; requirements for
additional financing; competition; hindering market growth or other
factors that may not currently be known by the Company.
There can be no assurance that such information will prove to be
accurate or that management's expectations or estimates of future
developments, circumstances or results will materialize. As a
result of these risks and uncertainties, the results or events
predicted in these forward-looking statements may differ materially
from actual results or events.
Accordingly, readers should not place undue reliance on
forward-looking statements. The forward-looking statements in this
news release are made as of the date of this release. Skylight
Health disclaims any intention or obligation to update or revise
such information, except as required by applicable law, and
Skylight Health does not assume any liability for disclosure
relating to any other company mentioned herein.
Neither the TSX Venture Exchange nor its
Regulation Services Provider (as that term is defined in the
policies of the TSX Venture Exchange) accepts responsibility for
the adequacy or accuracy of this release.
Skylight Health (NASDAQ:SLHG)
Historical Stock Chart
From Aug 2024 to Sep 2024
Skylight Health (NASDAQ:SLHG)
Historical Stock Chart
From Sep 2023 to Sep 2024